First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors
Simple Summary
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hartmann, K. Clinical aspects of feline retroviruses: A review. Viruses 2012, 4, 2684–2710. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Sykes, J.E. Feline Immunodeficiency Virus Infection. Canine Feline Infect. Dis. 2014, 209–223. [Google Scholar] [CrossRef] [PubMed Central]
- Westman, M.E.; Malik, R.; Norris, J.M. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: An update for clinicians. Aust. Vet. J. 2019, 97, 47–55, Erratum in: Aust. Vet. J. 2019, 97, 371. [Google Scholar] [CrossRef] [PubMed]
- Powers, J.A.; Chiu, E.S.; Kraberger, S.J.; Roelke-Parker, M.; Lowery, I.; Erbeck, K.; Troyer, R.; Carver, S.; VandeWoude, S. Feline Leukemia Virus (FeLV) Disease Outcomes in a Domestic Cat Breeding Colony: Relationship to Endogenous FeLV and Other Chronic Viral Infections. J. Virol. 2018, 92, e00649-18. [Google Scholar] [CrossRef] [PubMed]
- Lutz, H.; Addie, D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hartmann, K.; Hosie, M.J.; Lloret, A.; et al. Feline leukaemia. ABCD guidelines on prevention and management. J. Feline Med. Surg. 2009, 11, 565–574. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tozon, N.; Nemec, A.S.; Zemljic, M.; Zakosek, M. High prevalence of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) in Slovenia. Acta Vet. 2008, 58, 191–201. [Google Scholar] [CrossRef]
- Major, A.; Cattori, V.; Boenzli, E.; Riond, B.; Ossent, P.; Meli, M.L.; Hofmann-Lehmann, R.; Lutz, H. Exposure of cats to low doses of FeLV: Seroconversion as the sole parameter of infection. Vet. Res. 2010, 41, 17. [Google Scholar] [CrossRef]
- Hofmann-Lehmann, R.; Hartmann, K. Feline Leukemia Virus Infection—ABCD recommendations and review of the literature. ABCD 2021. Available online: https://www.abcdcatsvets.org/wp-content/uploads/2023/01/ABCD-FeLV-Guideline-2021.pdf (accessed on 3 November 2024).
- Levy, J.K. FeLV and non-neoplastic felv-related disease. In Textbook of Veterinary Internal Medicine; Ettinger, S.J., Feldman, E.C., Eds.; Saunders: Philadelphia, PA, USA, 2000. [Google Scholar]
- Ludwick, K.; Clymer, J.W. Comparative meta-analysis of feline leukemia virus and feline immunodeficiency virus seroprevalence correlated with GDP per capita around the globe. Res. Vet. Sci. 2019, 125, 89–93. [Google Scholar] [CrossRef] [PubMed]
- Muchaamba, F.; Mutiringindi, T.H.; Tivapasia, M.T.; Dhliwayo, S.; Matope, G. A survey of feline leukemia virus infection of domestic cats from selected areas in Harare, Zimbabwe. J. S. Afr. Vet. Assoc. 2014, 85, 1–6. [Google Scholar] [CrossRef]
- Tiao, N.; Darrington, C.; Molla, B.; Saville, W.J.; Tilahun, G.; Kwok, O.C.; Gebreyes, W.A.; Lappin, M.R.; Jones, J.L.; Dubey, J.P. An investigation into the seroprevalence of Toxoplasma gondii, Bartonella spp., feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) in cats in Addis Ababa, Ethiopia. Epidemiol. Infect. 2013, 141, 1029–1033. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Al-Kappany, Y.M.; Lappin, M.R.; Kwok, O.C.; Abu-Elwafa, S.A.; Hilali, M.; Dubey, J.P. Seroprevalence of Toxoplasma gondii and concurrent Bartonella spp., feline immunodeficiency virus, feline leukemia virus, and Dirofilaria immitis infections in Egyptian cats. J. Parasitol. 2011, 97, 256–258. [Google Scholar] [CrossRef] [PubMed]
- Hosmer, D.W.; Lemeshow, S. Applied Logistic Regression; John Wiley & Sons: New York, NY, USA, 2000; p. 375. [Google Scholar]
- Dohoo, I.R.; Ducroc, C.; Fourichon, C.; Donald, A.; Hurnik, D. An overview of techniques for dealing with large numbers of independent variables in epidemiologic studies. Prev. Vet. Med. 1996, 29, 221–239. [Google Scholar] [CrossRef]
- Westman, M.E.; Coggins, S.J.; van Dorsselaer, M.; Norris, J.M.; Squires, R.A.; Thompson, M.; Malik, R. Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention, and management. Aust. Vet. J. 2022, 100, 345–359. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Studer, H.; Lutz, C.; Saegerman, E.; Gönczi, M.L.; Meli, M.L.; Boo, G.; Hartmann, K.; Hosie, M.J.; Moestl, K.; Tasker, S.; et al. Pan-European Study on the Prevalence of the Feline Leukemia Virus Infection—Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses 2019, 11, 993. [Google Scholar] [CrossRef]
- Fusco, G.; Marati, L.; Pugliese, A.; Levante, M.; Ferrara, G.; de Carlo, E.; Amoroso, M.G.; Montagnaro, S. Prevalence of feline leukemia virus and feline immunodeficiency virus in cats from southern Italy: A 10-year cross-sectional study. Front. Vet. Sci. 2023, 10, 1260081. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Villanueva-Saz, S.; Giner, J.; Tobajas, A.P.; Pérez, M.D.; González-Ramírez, A.M.; Macías-León, J.; González, A.; Verde, M.; Yzuel, A.; Hurtado-Guerrero, R.; et al. Serological evidence of SARS-CoV-2 and co-infections in stray cats in Spain. Transbound. Emerg. Dis. 2022, 69, 1056–1064. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Biezus, G.; Machado, G.; Ferian, P.E.; da Costa, U.M.; Pereira, L.H.H.D.S.; Withoeft, J.A.; Nunes, I.A.C.; Muller, T.R.; de Cristo, T.G.; Casagrande, R.A. Prevalence of and factors associated with feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) in cats of the state of Santa Catarina, Brazil. Comp. Immunol. Microbiol. Infect. Dis. 2019, 63, 17–21. [Google Scholar] [CrossRef] [PubMed]
- Muz, D.; Can, H.; Karakavuk, M.; Döşkaya, M.; Özdemir, H.G.; Döşkaya, A.D.; Şahar, E.A.; Pektaş, B.; Karakuş, M.; Töz, S.; et al. The molecular and serological investigation of Feline immunodeficiency virus and Feline leukemia virus in stray cats of Western Turkey. Comp. Immunol. Microbiol. Infect. Dis. 2021, 78, 101688. [Google Scholar] [CrossRef] [PubMed]
- Sprißler, F.; Jongwattanapisan, P.; Luengyosluechakul, S.; Pusoonthornthum, R.; Reese, S.; Bergmann, M.; Hartmann, K. Prevalence and Risk Factors of Feline Immunodeficiency Virus and Feline Leukemia Virus Infection in Healthy Cats in Thailand. Front. Vet. Sci. 2022, 8, 764217. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Gleich, S.E.; Krieger, S.; Hartmann, K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J. Feline Med. Surg. 2009, 11, 985–992. [Google Scholar] [CrossRef]
- Galdo Novo, S.; Bucafusco, D.; Diaz, L.M.; Bratanich, A.C. Viral diagnostic criteria for Feline immunodeficiency virus and Feline leukemia virus infections in domestic cats from Buenos Aires, Argentina. Rev. Argent. Microbiol. 2016, 48, 293–297. [Google Scholar] [CrossRef]
- Hartmann, K.; Hofmann-Lehmann, R. What’s New in Feline Leukemia Virus Infection. Vet. Clin. N. Am. Small Anim. Pract. 2020, 50, 1013–1036. [Google Scholar] [CrossRef]
- Khalife, S.; Kassaa, I.A. Occurrence and risk factors of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) in cats of Lebanon. Comp. Immunol. Microbiol. Infect. Dis. 2023, 93, 101931. [Google Scholar] [CrossRef] [PubMed]
- Tejerizo, G.; Domenech, A.; Illera, J.C.; Silvan, G.; Gomez-Lucia, E. Altered plasma concentrations of sex hormones in cats infected by feline immunodeficiency virus or feline leukemia virus. Domest. Anim. Endocrinol. 2012, 42, 113–120. [Google Scholar] [CrossRef]
- De Almeida, N.R.; Danelli, M.G.; da Silva, L.H.; Hagiwara, M.K.; Mazur, C. Prevalence of feline leukemia virus infection in domestic cats in Rio de Janeiro. J. Feline Med. Surg. 2012, 14, 583–586. [Google Scholar] [CrossRef] [PubMed]
- Hofmann-Lehmann, R.; Huder, J.B.; Gruber, S.; Boretti, F.; Sigrist, B.; Lutz, H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J. Gen. Virol. 2001, 82, 1589–1596. [Google Scholar] [CrossRef]
- Levy, J.K.; Crawford, P.C.; Slater, M.R. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats. J. Am. Vet. Med. Assoc. 2004, 225, 1558–1561. [Google Scholar] [CrossRef] [PubMed]
FIV Infection | FeLV Infection | |||||||
---|---|---|---|---|---|---|---|---|
Variable | Category | Tested | Positives | Prevalence% | p Value | Positives | Prevalence% | p Value |
Sex | Male | 39 | 13 | 33.33 | 10 | 25.64 | ||
Female | 32 | 10 | 31.25 | 0.654 | 6 | 18.75 | 0.035 * | |
Reproductive status | Neutered | 36 | 12 | 33.33 | 7 | 19.44 | ||
Intact | 35 | 11 | 31.42 | 0.619 | 9 | 25.71 | 0.041 * | |
Access to outdoor | Yes | 46 | 23 | 50 | 16 | 34.78 | ||
No | 25 | 0 | 0 | / | 0 | 0 | / | |
Housing | Street | 19 | 8 | 42.10 | 1 | 5.26 | ||
Shelter | 19 | 9 | 47.36 | 11 | 57.89 | |||
House | 33 | 6 | 18.18 | 0.034 * | 4 | 12.12 | 0.016 * | |
Breed | Purebred | 12 | 0 | 0 | 0 | 0 | ||
Mixed-breed | 59 | 23 | 38.98 | / | 16 | 27.11 | / | |
Age | 0–1 year | 22 | 7 | 31.81 | 3 | 13.63 | ||
2–3 years | 19 | 5 | 26.31 | 7 | 36.84 | |||
4–6 years | 23 | 10 | 43.47 | 0.029 * | 6 | 26.08 | 0.018 * | |
≥7 years | 7 | 1 | 14.28 | 0 | 0 | |||
Health status | Healthy | 40 | 7 | 17.5 | 1 | 2.5 | ||
Sick | 31 | 16 | 51.61 | 0.015 * | 15 | 48.38 | 0.001 * |
FIV Infection | FeLV Infection | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | Category | Tested | Positives | Prevalence% | OR | 95% IC | p Value | Positives | Prevalence% | OR | 95% IC | p Value |
Sex | Male | 39 | 13 | 33.33 | / | / | / | 10 | 25.64 | 1.51 | (1.09–2.33) | 0.035 * |
Female | 32 | 10 | 31.25 | / | / | 6 | 18.75 | Ref | ||||
Reproductive status | Neutered | 36 | 12 | 33.33 | / | / | / | 7 | 19.44 | Ref | ||
Intact | 35 | 11 | 31.42 | / | / | 9 | 25.71 | 1.39 | (1.11–1.88) | 0.048 * | ||
Access to outdoor | Yes | 46 | 23 | 50 | / | / | / | 16 | 34.78 | / | / | / |
No | 25 | 0 | 0 | / | / | 0 | 0 | / | / | / | ||
Housing | Street | 19 | 8 | 42.10 | 2.330 | 1.74–2.99 | 0.038 * | 1 | 5.26 | 0.88 | (0.55–1.26) | 0.094 |
Shelter | 19 | 9 | 47.36 | 2.48 | 1.92–3.58 | 0.034 * | 11 | 57.89 | 2.88 | (2.21–3.59) | 0.031 * | |
Housed cat | 33 | 6 | 18.18 | Ref | 4 | 12.12 | ||||||
Breed | Purebred | 12 | 0 | 0 | / | / | 0 | 0 | / | / | ||
Mixed-breed | 59 | 23 | 38.98 | / | / | 16 | 27.11 | / | / | |||
Age | 0–1 year | 22 | 7 | 31.81 | Ref | / | 3 | 13.63 | Ref | / | ||
2–3 years | 19 | 5 | 26.31 | 1.12 | 0.41–1.65 | 0.32 | 7 | 36.84 | 2.95 | (1.88–3.72) | 0.029 * | |
4–6 years | 23 | 10 | 43.47 | 1.87 | 1.22–2.69 | 0.041 * | 6 | 26.08 | 2.14 | (1.35–3.66) | 0.028 * | |
≥7 years | 7 | 1 | 14.28 | / | 0 | 0 | / | / | / | |||
Health status | Healthy | 40 | 7 | 17.5 | Ref | 1 | 2.5 | Ref | ||||
Sick | 31 | 16 | 51.61 | 2.84 | 1.66–3.92 | 0.035 * | 15 | 48.38 | 3.22 | (1.51–5.62) | 0.031 * |
Variable | Category | Tested | Positives | Prevalence% | OR | 95% IC | p Value |
---|---|---|---|---|---|---|---|
Sex | Male | 39 | 5 | 12.82 | / | / | / |
Female | 32 | 3 | 9.37 | / | / | / | |
Reproductive status | neutered | 36 | 6 | 16.66 | 2.57 | (1.45–3.81) | 0.027 * |
Intact | 35 | 2 | 5.71 | Ref | |||
Access to outdoor | yes | 46 | 8 | 17.39 | / | / | / |
no | 25 | 0 | 0 | / | / | / | |
Housing | street | 19 | 0 | 0 | / | ||
shelter | 19 | 7 | 36.84 | 6.22 | 2.66–11.35 | 0.034 * | |
House cat | 33 | 1 | 3.03 | Ref | |||
Breed | Purebred | 12 | 1 | 8.33 | / | / | / |
Mixed-breed | 59 | 7 | 11.86 | / | / | / | |
Age | 0–1 year | 22 | 1 | 4.54 | Ref | ||
2–3 years | 19 | 3 | 15.78 | 3.11 | 1.54–4.88 | 0.041 * | |
4–6 years | 23 | 4 | 17.39 | 3.81 | 2.14–6.38 | 0.035 * | |
≥7 years | 7 | 0 | 0 | / | / | / | |
Health status | Healthy | 40 | 0 | 0 | / | / | / |
Sick | 31 | 8 | 25.80 | / | / | / |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yahiaoui, F.; Kardjadj, M.; Ben-Mahdi, M.H. First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors. Vet. Sci. 2024, 11, 546. https://doi.org/10.3390/vetsci11110546
Yahiaoui F, Kardjadj M, Ben-Mahdi MH. First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors. Veterinary Sciences. 2024; 11(11):546. https://doi.org/10.3390/vetsci11110546
Chicago/Turabian StyleYahiaoui, Fatima, Moustafa Kardjadj, and Meriem Hind Ben-Mahdi. 2024. "First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors" Veterinary Sciences 11, no. 11: 546. https://doi.org/10.3390/vetsci11110546
APA StyleYahiaoui, F., Kardjadj, M., & Ben-Mahdi, M. H. (2024). First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors. Veterinary Sciences, 11(11), 546. https://doi.org/10.3390/vetsci11110546